COVID mortality age patterns changed significantly during pandemic COVID mortality age patterns changed significantly during pandemic Between March 2020 and October 2021, death rates from the virus decreased for those 80 and older and increased for those 25 to 54, results that held across racial and ethnic groups.
DNA analysis finds links between severe COVID and other conditions DNA analysis finds links between severe COVID and other conditions Through analyzing human DNA samples in a large biobank, Penn Medicine researchers found associations between genetic variants with severe COVID and conditions involving blood clots and respiratory issues.
Ross Prize awarded to mRNA technology, COVID-19 vaccine innovators Penn In the News Business Wire Ross Prize awarded to mRNA technology, COVID-19 vaccine innovators Katalin Karikó and Drew Weissman of the Perelman School of Medicine will be honored at a June 7 symposium in New York City for their research that enabled COVID-19 vaccines. Local doctor answers COVID-19 long haul questions Penn In the News Fox 29 (Philadelphia) Local doctor answers COVID-19 long haul questions Benjamin Abramoff of the Perelman School of Medicine answers questions about COVID long haul symptoms. A Wharton initiative championing global change The Zicklin Center for Business Ethics Research at the Wharton School, Penn, and its many partners issued a call for proposals for an initiative: Building Capacity to Combat COVID-19 in Africa: Ideas and Innovations from Young Entrepreneurs. (Image: Ideas for Action, The Wharton School) Q&A A Wharton initiative championing global change The Ideas for Action Wharton undergraduate student club is a joint initiative with the Zicklin Center for Business Ethics Research to engage youth around the world in developing solutions to global challenges. Could a single vaccine fend off all versions of COVID-19? Here’s where the science stands Penn In the News San Francisco Chronicle Could a single vaccine fend off all versions of COVID-19? Here’s where the science stands Drew Weissman of the Perelman School of Medicine is featured for work he is doing to develop a pancoronavirus vaccine, a vaccine that would offer protection from all types of coronaviruses like COVID-19, SARS, and others. COVID-19 turned everything upside down. What has Penn Medicine’s innovation team learned? Image: Penn Medicine News COVID-19 turned everything upside down. What has Penn Medicine’s innovation team learned? To many in health care—including those in Penn Medicine’s Center for Health Care Innovation—the COVID-19 pandemic is a crisis from which to find the next great learning opportunity. From a pandemic, scientific insights poised to impact more than just COVID-19 Bijels, or bicontinuous interfacially jammed emulsion gels, are structured emulsions of oil and water that are kept separated by a layer of nanoparticles. Penn Engineering researchers will develop a way of using them to manufacture mRNA-based therapeutics. (Image: Penn Engineering Today) From a pandemic, scientific insights poised to impact more than just COVID-19 Pivoting to study SARS-CoV-2, many scientists on campus have launched new research projects that address the challenges of the pandemic but also prepare us to confront future challenges. COVID vaccine’s mRNA technology also works for an HIV vaccine, study shows Penn In the News WHYY (Philadelphia) COVID vaccine’s mRNA technology also works for an HIV vaccine, study shows Drew Weissman of the Perelman School of Medicine led a study that proves that mRNA technology could be used to deliver an HIV vaccine. Future research will explore developing mRNA vaccines for herpes, influenza, and other viruses. Belief in vaccination misinformation predicts attitudes toward vaccinating children Belief in vaccination misinformation predicts attitudes toward vaccinating children The survey data come from the fifth wave of the Annenberg Science Knowledge survey, a nationally representative sample of U.S. adults empaneled by the Annenberg Public Policy Center in April 2021 to track attitudes and behavior in the pandemic. Load More
Local doctor answers COVID-19 long haul questions Penn In the News Fox 29 (Philadelphia) Local doctor answers COVID-19 long haul questions Benjamin Abramoff of the Perelman School of Medicine answers questions about COVID long haul symptoms. A Wharton initiative championing global change The Zicklin Center for Business Ethics Research at the Wharton School, Penn, and its many partners issued a call for proposals for an initiative: Building Capacity to Combat COVID-19 in Africa: Ideas and Innovations from Young Entrepreneurs. (Image: Ideas for Action, The Wharton School) Q&A A Wharton initiative championing global change The Ideas for Action Wharton undergraduate student club is a joint initiative with the Zicklin Center for Business Ethics Research to engage youth around the world in developing solutions to global challenges. Could a single vaccine fend off all versions of COVID-19? Here’s where the science stands Penn In the News San Francisco Chronicle Could a single vaccine fend off all versions of COVID-19? Here’s where the science stands Drew Weissman of the Perelman School of Medicine is featured for work he is doing to develop a pancoronavirus vaccine, a vaccine that would offer protection from all types of coronaviruses like COVID-19, SARS, and others. COVID-19 turned everything upside down. What has Penn Medicine’s innovation team learned? Image: Penn Medicine News COVID-19 turned everything upside down. What has Penn Medicine’s innovation team learned? To many in health care—including those in Penn Medicine’s Center for Health Care Innovation—the COVID-19 pandemic is a crisis from which to find the next great learning opportunity. From a pandemic, scientific insights poised to impact more than just COVID-19 Bijels, or bicontinuous interfacially jammed emulsion gels, are structured emulsions of oil and water that are kept separated by a layer of nanoparticles. Penn Engineering researchers will develop a way of using them to manufacture mRNA-based therapeutics. (Image: Penn Engineering Today) From a pandemic, scientific insights poised to impact more than just COVID-19 Pivoting to study SARS-CoV-2, many scientists on campus have launched new research projects that address the challenges of the pandemic but also prepare us to confront future challenges. COVID vaccine’s mRNA technology also works for an HIV vaccine, study shows Penn In the News WHYY (Philadelphia) COVID vaccine’s mRNA technology also works for an HIV vaccine, study shows Drew Weissman of the Perelman School of Medicine led a study that proves that mRNA technology could be used to deliver an HIV vaccine. Future research will explore developing mRNA vaccines for herpes, influenza, and other viruses. Belief in vaccination misinformation predicts attitudes toward vaccinating children Belief in vaccination misinformation predicts attitudes toward vaccinating children The survey data come from the fifth wave of the Annenberg Science Knowledge survey, a nationally representative sample of U.S. adults empaneled by the Annenberg Public Policy Center in April 2021 to track attitudes and behavior in the pandemic. Load More
A Wharton initiative championing global change The Zicklin Center for Business Ethics Research at the Wharton School, Penn, and its many partners issued a call for proposals for an initiative: Building Capacity to Combat COVID-19 in Africa: Ideas and Innovations from Young Entrepreneurs. (Image: Ideas for Action, The Wharton School) Q&A A Wharton initiative championing global change The Ideas for Action Wharton undergraduate student club is a joint initiative with the Zicklin Center for Business Ethics Research to engage youth around the world in developing solutions to global challenges.
Could a single vaccine fend off all versions of COVID-19? Here’s where the science stands Penn In the News San Francisco Chronicle Could a single vaccine fend off all versions of COVID-19? Here’s where the science stands Drew Weissman of the Perelman School of Medicine is featured for work he is doing to develop a pancoronavirus vaccine, a vaccine that would offer protection from all types of coronaviruses like COVID-19, SARS, and others. COVID-19 turned everything upside down. What has Penn Medicine’s innovation team learned? Image: Penn Medicine News COVID-19 turned everything upside down. What has Penn Medicine’s innovation team learned? To many in health care—including those in Penn Medicine’s Center for Health Care Innovation—the COVID-19 pandemic is a crisis from which to find the next great learning opportunity. From a pandemic, scientific insights poised to impact more than just COVID-19 Bijels, or bicontinuous interfacially jammed emulsion gels, are structured emulsions of oil and water that are kept separated by a layer of nanoparticles. Penn Engineering researchers will develop a way of using them to manufacture mRNA-based therapeutics. (Image: Penn Engineering Today) From a pandemic, scientific insights poised to impact more than just COVID-19 Pivoting to study SARS-CoV-2, many scientists on campus have launched new research projects that address the challenges of the pandemic but also prepare us to confront future challenges. COVID vaccine’s mRNA technology also works for an HIV vaccine, study shows Penn In the News WHYY (Philadelphia) COVID vaccine’s mRNA technology also works for an HIV vaccine, study shows Drew Weissman of the Perelman School of Medicine led a study that proves that mRNA technology could be used to deliver an HIV vaccine. Future research will explore developing mRNA vaccines for herpes, influenza, and other viruses. Belief in vaccination misinformation predicts attitudes toward vaccinating children Belief in vaccination misinformation predicts attitudes toward vaccinating children The survey data come from the fifth wave of the Annenberg Science Knowledge survey, a nationally representative sample of U.S. adults empaneled by the Annenberg Public Policy Center in April 2021 to track attitudes and behavior in the pandemic. Load More
COVID-19 turned everything upside down. What has Penn Medicine’s innovation team learned? Image: Penn Medicine News COVID-19 turned everything upside down. What has Penn Medicine’s innovation team learned? To many in health care—including those in Penn Medicine’s Center for Health Care Innovation—the COVID-19 pandemic is a crisis from which to find the next great learning opportunity.
From a pandemic, scientific insights poised to impact more than just COVID-19 Bijels, or bicontinuous interfacially jammed emulsion gels, are structured emulsions of oil and water that are kept separated by a layer of nanoparticles. Penn Engineering researchers will develop a way of using them to manufacture mRNA-based therapeutics. (Image: Penn Engineering Today) From a pandemic, scientific insights poised to impact more than just COVID-19 Pivoting to study SARS-CoV-2, many scientists on campus have launched new research projects that address the challenges of the pandemic but also prepare us to confront future challenges.
COVID vaccine’s mRNA technology also works for an HIV vaccine, study shows Penn In the News WHYY (Philadelphia) COVID vaccine’s mRNA technology also works for an HIV vaccine, study shows Drew Weissman of the Perelman School of Medicine led a study that proves that mRNA technology could be used to deliver an HIV vaccine. Future research will explore developing mRNA vaccines for herpes, influenza, and other viruses. Belief in vaccination misinformation predicts attitudes toward vaccinating children Belief in vaccination misinformation predicts attitudes toward vaccinating children The survey data come from the fifth wave of the Annenberg Science Knowledge survey, a nationally representative sample of U.S. adults empaneled by the Annenberg Public Policy Center in April 2021 to track attitudes and behavior in the pandemic.
Belief in vaccination misinformation predicts attitudes toward vaccinating children Belief in vaccination misinformation predicts attitudes toward vaccinating children The survey data come from the fifth wave of the Annenberg Science Knowledge survey, a nationally representative sample of U.S. adults empaneled by the Annenberg Public Policy Center in April 2021 to track attitudes and behavior in the pandemic.